Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference newsletter


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 54 articles:
HTML format



Single Articles


    August 2020
  1. HERMENS M, van Altena AM, van der Aa M, Bulten J, et al
    Ovarian cancer prognosis in women with endometriosis. A retrospective nationwide cohort study of 32,419 women.
    Am J Obstet Gynecol. 2020 Aug 22. pii: S0002-9378(20)30883.
    PubMed     Abstract available


    June 2020
  2. FREY MK, Ellis AE, Zeligs K, Chapman-Davis E, et al
    Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2020 Jun 26. pii: S0002-9378(20)30674.
    PubMed     Abstract available


    May 2020
  3. VETTER MH, Smrz SA, Copeland LJ, Cohn DE, et al
    Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19.
    Am J Obstet Gynecol. 2020 May 23. pii: S0002-9378(20)30569.
    PubMed    


  4. GUO XM, Hall EF, Mazzullo L, Djordjevic M, et al
    A low-cost approach to salpingectomy at cesarean delivery.
    Am J Obstet Gynecol. 2020;222:503.
    PubMed     Abstract available


    February 2020
  5. HANLEY GE, Kwon JS, McAlpine JN, Huntsman DG, et al
    Examining indicators of early menopause following opportunistic salpingectomy: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2020 Feb 14. pii: S0002-9378(20)30143.
    PubMed     Abstract available


    January 2020
  6. HERMENS M, van Altena AM, Nieboer TE, Schoot BC, et al
    Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis. The ENOCA population-based cohort study.
    Am J Obstet Gynecol. 2020 Jan 22. pii: S0002-9378(20)30062.
    PubMed     Abstract available


    November 2019
  7. GREGORI-GARCIA E, Rodriguez-Garcia V, Burgues O, Martinez J, et al
    Differential expression of Receptor Activator of Nuclear Factor Kappa B in healthy endometrium, ovarian endometrioma and endometrioid ovarian cancer.
    Am J Obstet Gynecol. 2019 Nov 22. pii: S0002-9378(19)32638.
    PubMed    


  8. FACER B, Wang F, Grijalva CG, Alvarez RD, et al
    Survival Outcomes for Robotic-Assisted Laparoscopy Versus Traditional Laparoscopy in Clinical Stage I Epithelial Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Nov 9. pii: S0002-9378(19)32614.
    PubMed     Abstract available


    September 2019
  9. LAGO V, Domingo S
    New horizons of sentinel lymph node technique in early ovarian cancer.
    Am J Obstet Gynecol. 2019 Sep 19. pii: S0002-9378(19)31125.
    PubMed    


  10. UCCELLA S, Fagotti A, Scambia G
    SENTINEL NODE IN OVARIAN CANCER: A CHALLENGE TO WIN.
    Am J Obstet Gynecol. 2019 Sep 18. pii: S0002-9378(19)31122.
    PubMed    


  11. CHAM S, Wen T, Friedman A, Wright JD, et al
    Fragmentation of postoperative care after surgical management of ovarian cancer at 30-days and 90-days.
    Am J Obstet Gynecol. 2019 Sep 11. pii: S0002-9378(19)31110.
    PubMed     Abstract available


    August 2019
  12. KLEIN DA, Mann AK, Freeman AH, Liao CI, et al
    Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer - is interval cytoreductive surgery still needed?
    Am J Obstet Gynecol. 2019 Aug 14. pii: S0002-9378(19)31011.
    PubMed     Abstract available


  13. VETTER MH, Smith B, Benedict J, Hade EM, et al
    Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
    Am J Obstet Gynecol. 2019 Aug 8. pii: S0002-9378(19)31000.
    PubMed     Abstract available


    July 2019
  14. GENTRY-MAHARAJ A, Burnell M, Dilley J, Ryan A, et al
    Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
    Am J Obstet Gynecol. 2019 Jul 24. pii: S0002-9378(19)30936.
    PubMed     Abstract available


  15. TARNEY CM, Wang G, Bateman NW, Conrads KA, et al
    Biomarker Panel for Early Detection of Endometrial Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30769.
    PubMed     Abstract available


    June 2019
  16. GOCKLEY A, Melamed A, Cronin A, Bookman MA, et al
    Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
    Am J Obstet Gynecol. 2019 Jun 14. pii: S0002-9378(19)30773.
    PubMed     Abstract available


    May 2019
  17. DAI Y, Zhang J, Ren H, Zhou X, et al
    Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Am J Obstet Gynecol. 2019 May 22. pii: S0002-9378(19)30684.
    PubMed     Abstract available


  18. DOLL KM, Winn A
    Assessing Endometrial Cancer Risk Among US Women: Long-Term Trends using Hysterectomy-Adjusted Analysis.
    Am J Obstet Gynecol. 2019 May 21. pii: S0002-9378(19)30682.
    PubMed     Abstract available


  19. UCCELLA S, Nero C, Vizza E, Vargiu V, et al
    Sentinel-Node Biopsy in Early Stage Ovarian Cancer: Preliminary Results of a Prospective Multicentre Study (SELLY).
    Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30660.
    PubMed     Abstract available


  20. MANNING-GEIST BL, Hicks-Courant K, Gockley AA, Clark RM, et al
    A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Am J Obstet Gynecol. 2019 May 10. pii: S0002-9378(19)30661.
    PubMed     Abstract available


  21. HOLLIS RL, Carmichael J, Meynert AM, Churchman M, et al
    Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.
    Am J Obstet Gynecol. 2019 May 2. pii: S0002-9378(19)30620.
    PubMed     Abstract available


    April 2019
  22. SUIDAN RS, He W, Sun CC, Zhao H, et al
    Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
    Am J Obstet Gynecol. 2019 Apr 6. pii: S0002-9378(19)30565.
    PubMed     Abstract available


    March 2019
  23. GIBBS J, Mei S, Economos K, Lee YC, et al
    Clinicopathologic features, incidence and survival trends of gynecologic neuroendocrine tumors; a SEER data base analysis.
    Am J Obstet Gynecol. 2019 Mar 5. pii: S0002-9378(19)30431.
    PubMed     Abstract available


    February 2019
  24. CHAM S, Chen L, St Clair CM, Hou JY, et al
    Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Feb 13. pii: S0002-9378(19)30360.
    PubMed     Abstract available


    January 2019
  25. VENKATESH KK, Clark LH, Stamilio DM
    Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Am J Obstet Gynecol. 2019;220:106.
    PubMed     Abstract available


    December 2018
  26. OKAZAKI A, Nishi K, Kasahara K
    Pseudo-Meigs Syndrome Caused by Cancer of the Uterine Corpus.
    Am J Obstet Gynecol. 2018 Dec 7. pii: S0002-9378(18)32217.
    PubMed    


    October 2018
  27. COLLINS E, Strandell A, Granasen G, Idahl A, et al
    Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study.
    Am J Obstet Gynecol. 2018 Oct 12. pii: S0002-9378(18)30898.
    PubMed     Abstract available


    September 2018
  28. ACKROYD SA, Brown J, Houck K, Chu C, et al
    A preoperative risk score to predict red blood cell transfusion in patients undergoing hysterectomy for ovarian cancer.
    Am J Obstet Gynecol. 2018 Sep 18. pii: S0002-9378(18)30759.
    PubMed     Abstract available


    August 2018
  29. TAMAUCHI S, Kajiyama H, Yoshihara M, Ikeda Y, et al
    Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.
    Am J Obstet Gynecol. 2018 Aug 4. pii: S0002-9378(18)30608.
    PubMed     Abstract available


    May 2018
  30. HANLEY GE, Kwon JS, Finlayson SJ, Huntsman DG, et al
    Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: A cohort study from British Columbia, Canada.
    Am J Obstet Gynecol. 2018 May 28. pii: S0002-9378(18)30429.
    PubMed     Abstract available


  31. GEMER O, Segev Y, Helpman L, Hag-Yahia N, et al
    Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Am J Obstet Gynecol. 2018 May 21. pii: S0002-9378(18)30408.
    PubMed     Abstract available


    April 2018
  32. PATEL S, Legood R, Evans DG, Turnbull C, et al
    Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women.
    Am J Obstet Gynecol. 2018;218:431.
    PubMed     Abstract available


    March 2018
  33. ADELMAN MR, Sharp HT
    Ovarian conservation vs removal at the time of benign hysterectomy.
    Am J Obstet Gynecol. 2018;218:269-279.
    PubMed     Abstract available


    January 2018
  34. BOAC BM, Xiong Y, Apte SM, Wenham RM, et al
    Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
    Am J Obstet Gynecol. 2018 Jan 15. pii: S0002-9378(18)30018.
    PubMed     Abstract available


  35. GOETSCH MF
    Management of sexuality, intimacy, and menopause symptoms after ovarian cancer.
    Am J Obstet Gynecol. 2018 Jan 4. pii: S0002-9378(18)30001.
    PubMed    


    November 2017
  36. MANCHANDA R, Patel S, Antoniou AC, Levy-Lahad E, et al
    Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
    Am J Obstet Gynecol. 2017;217:578.
    PubMed     Abstract available


    October 2017
  37. ALMASI-HASHIANI A, Ayubi E, Safiri S
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer: Methodological issues.
    Am J Obstet Gynecol. 2017 Oct 17. pii: S0002-9378(17)31203.
    PubMed    


  38. BISHOP EA, Java JJ, Moore KN, Spirtos NM, et al
    Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: A NRG/Gynecologic Oncology Group Study.
    Am J Obstet Gynecol. 2017 Oct 13. pii: S0002-9378(17)31189.
    PubMed     Abstract available


    August 2017
  39. RUIZ MP, Huang Y, Hou JY, Tergas AI, et al
    All-Cause Mortality in Young Women with Endometrial Cancer Receiving Progesterone Therapy.
    Am J Obstet Gynecol. 2017 Aug 24. pii: S0002-9378(17)30942.
    PubMed     Abstract available


    July 2017
  40. ABRAMOWICZ JS, Timmerman D
    Ovarian mass-differentiating benign from malignant. The value of the International Ovarian Tumor Analysis (IOTA) ultrasound rules.
    Am J Obstet Gynecol. 2017 Jul 20. pii: S0002-9378(17)30861.
    PubMed     Abstract available


  41. ANTOSH DD, High R, Brown HW, Oliphant SS, et al
    Feasibility of Prophylactic Salpingectomy During Vaginal Hysterectomy.
    Am J Obstet Gynecol. 2017 Jul 19. pii: S0002-9378(17)30859.
    PubMed     Abstract available


  42. MARGOLIS B, Chen L, Accordino MK, Hillyer GC, et al
    Trends in End of Life Care and Healthcare Spending in Women with Uterine Cancer.
    Am J Obstet Gynecol. 2017 Jul 11. pii: S0002-9378(17)30848.
    PubMed     Abstract available


    June 2017
  43. MATSUO K, Machida H, Horowitz MP, Shahzad MMK, et al
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Am J Obstet Gynecol. 2017 Jun 27. pii: S0002-9378(17)30788.
    PubMed     Abstract available


  44. CADISH LA, Shepherd JP, Barber EL, Ridgeway B, et al
    Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy : A decision analysis.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30743.
    PubMed     Abstract available


  45. MOULTON L, Jernigan AM, Carr C, Freeman L, et al
    Single Port Laparoscopy in Gynecologic Oncology: Seven Years of Experience at a Single Institution.
    Am J Obstet Gynecol. 2017 Jun 12. pii: S0002-9378(17)30744.
    PubMed     Abstract available


    May 2017
  46. PETRILLO M, Marchetti C, De Leo R, Musella A, et al
    Brca Mutational Status, Initial Disease Presentation and Clinical Outcome in High-Grade Serous Advanced Ovarian Cancer: A Multicenter Study.
    Am J Obstet Gynecol. 2017 May 23. pii: S0002-9378(17)30647.
    PubMed     Abstract available


    April 2017
  47. WHICKER M, Black J, Altwerger G, Menderes G, et al
    Management of Sexuality, Intimacy, and Menopause Symptoms (SIMS) in Ovarian Cancer Patients: Expert Review.
    Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30513.
    PubMed     Abstract available


  48. RING KL, Garcia C, Thomas MH, Modesitt SC, et al
    Current and Future Role of Genetic Screening in Gynecologic Malignancies.
    Am J Obstet Gynecol. 2017 Apr 11. pii: S0002-9378(17)30512.
    PubMed     Abstract available


    March 2017
  49. CHEN PH
    The yolky thecoma.
    Am J Obstet Gynecol. 2017;216:318.
    PubMed    


    February 2017
  50. MOORE RG, Plante B, Hartnett E, Mitchel J, et al
    Assessment of serum HE4 levels throughout the normal menstrual cycle.
    Am J Obstet Gynecol. 2017 Feb 22. pii: S0002-9378(17)30320.
    PubMed     Abstract available


    January 2017
  51. STANHISER J, Chagin K, Jelovsek JE
    A Model to Predict Risk of Blood Transfusion After Gynecologic Surgery.
    Am J Obstet Gynecol. 2017 Jan 16. pii: S0002-9378(17)30104.
    PubMed     Abstract available


    October 2016
  52. HANLEY GE, McAlpine JN, Pearce CL, Miller D, et al
    The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2016 Oct 31. pii: S0002-9378(16)30971.
    PubMed     Abstract available


    July 2016
  53. BINDER PS, Peipert JF, Kallogjeri D, Brooks RA, et al
    Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Am J Obstet Gynecol. 2016 Jul 22. pii: S0002-9378(16)30470.
    PubMed     Abstract available


  54. FRANCHI D, Boveri S, Radice D, Portuesi R, et al
    Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for Borderline Ovarian tumors.
    Am J Obstet Gynecol. 2016 Jul 18. pii: S0002-9378(16)30458.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: